SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging due to extreme volatility and high interest in its low-float structure, as traders pivot toward energy stocks amid renewed geopolitical tensions and supply disruptions in the Middle East. The community is actively debating the stock's squeeze potential while focusing on the broader, long-term thesis regarding Europe's urgent need for domestic natural gas reserves.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors weigh aggressive M&A expansion plans led by CEO Brad Jacobs against recent volatility, with community debate centered on whether to treat current price weakness as a long-term accumulation opportunity or a signal of overvaluation. The stock remains a focal point for discussion around its role in the building materials sector, with participants closely monitoring for the next acquisition announcement to provide renewed momentum.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is navigating significant volatility as the industry grapples with an unprecedented government shutdown that has triggered FAA-mandated flight capacity cuts and severe air traffic controller staffing shortages. Investors are intensely debating whether the airline's premium loyalty model provides a durable margin cushion or if the escalating operational disruptions and fuel price pressures from broader Middle East instability will weigh on upcoming performance.

Forum Energy Technologies, Inc. designs, manufactures, and distributes products to the oil and natural gas industry. It operates through the Drilling and Completions and Artificial Lift and Downhole segments. The Drilling and Completions segment designs, manufactures and supplies products and solutions to the drilling, subsea, coiled tubing, well stimulation and intervention markets, including applications in oil and natural gas, renewable energy, defense and communications. The Artificial Lift and Downhole segment designs, manufactures and supplies products and solutions for the artificial lift, production and infrastructure markets. The company was founded in 2005 and is headquartered in Houston, TX.

Forum Energy Technologies Inc

Forum Energy Technologies is attracting investor attention as its recent Variperm acquisition and deleveraging efforts signal a shift toward stronger free cash flow and potential share repurchases. The community is actively discussing the stock's valuation disconnect and its positioning as a key beneficiary of resilient international activity and rebounding natural gas drilling demand.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing significant volatility driven by the recent release of a negative short report and investor reactions to a large block share sale. Despite the pressure, the community remains heavily focused on the company's long-term potential as a domestic solar manufacturer, closely monitoring institutional buy-ins and expectations for upcoming earnings and offtake agreements.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors await critical updates following recent FDA interactions, with the community closely tracking potential news regarding the accelerated approval pathway for its lead ALS candidate, CNM-Au8. Discussions are heavily focused on the anticipation of new biomarker data and potential NDA submission updates, which shareholders view as primary catalysts for a significant valuation rerating.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as investors weigh potential federal regulatory shifts alongside a notable surge in beverage segment revenue, which some analysts believe could scale exponentially by the next decade. The community remains focused on the long-term impact of rescheduling and institutional accumulation, with many shareholders emphasizing patience as they navigate short-term price volatility and sector-wide regulatory developments.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing significant community attention as investors debate its potential for a major breakout, with many highlighting its resilience and year-to-date performance relative to other leading cryptocurrencies. The sentiment remains polarized, with bullish traders pointing toward upcoming network upgrades and whale accumulation, while skeptics express frustration over stagnant price action and compare the asset to other market alternatives.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is experiencing significant volatility as the market reacts to intense geopolitical instability in the Middle East, specifically regarding energy infrastructure and the potential closure of the Strait of Hormuz. Community discussion is sharply divided between bulls betting on a massive supply-driven price spike due to infrastructure damage, and bears highlighting the leveraged decay inherent in the product alongside bearish seasonal demand factors.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing heightened community discussion surrounding the highly anticipated Goliath mainnet launch and potential enterprise-grade infrastructure developments. Investors are actively debating the token's long-term utility versus its history of volatility, with many monitoring for a sustained breakout while others caution against what they perceive as repetitive pump-and-dump market cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alumis (NASDAQ:ALMS) Price Target Raised to $38.00

Morgan Stanley lifted their price target on Alumis from $33.00 to $38.00 and gave the stock an "overweight" rating in a report on Friday...

Alumis (NASDAQ:ALMS) Given New $38.00 Price Target at Chardan Capital

Chardan Capital boosted their price target on Alumis from $37.00 to $38.00 and gave the stock a "buy" rating in a research report on Friday...

Alumis (NASDAQ:ALMS) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Alumis (NASDAQ:ALMS - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.90) by ($0.04). The company had revenue of $1.93 million for the quarter, compared to analyst...

Alumis (NASDAQ:ALMS) Trading Down 3.5% - Here's What Happened

Alumis (NASDAQ:ALMS) Stock Price Down 3.5% - Here's Why...

Alumis Inc. (NASDAQ:ALMS) Sees Significant Drop in Short Interest

Alumis Inc. (NASDAQ:ALMS - Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 7,953,241...

Alumis (NASDAQ:ALMS) Stock Price Down 6.7% - Should You Sell?

Alumis (NASDAQ:ALMS) Shares Down 6.7% - Here's Why...

Alumis (ALMS) to Release Earnings on Wednesday

Alumis (NASDAQ:ALMS) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...

Alumis Teases TYK2 Catalysts at Leerink: Phase III Psoriasis Wins, NDA Plan and Lupus Readout Ahead

Alumis (NASDAQ:ALMS) executives highlighted recent clinical progress for the company's TYK2 inhibitor programs and previewed multiple upcoming catalysts during remarks at the Leerink Partners Global...

Alumis Inc. (NASDAQ:ALMS) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the twelve brokerages that are currently covering the company, Marketbeat Ratings...

Alumis Shares Phase 3 Psoriasis Details, Targets 2H NDA Filing at Oppenheimer Healthcare Conference

Executives from Alumis (NASDAQ:ALMS) outlined upcoming regulatory milestones and provided additional context around recently announced Phase 3 psoriasis results for envudeucitinib during a fireside...

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

ALMS
Alumis Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALMS News

ALMSAlumis Inc.